GNPX
GNPX
NASDAQ · Biotechnology

Genprex Inc

$2.20
+0.24 (+12.24%)
As of Feb 8, 2:32 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.53M 1.54M 1.49M
Net Income 146.8K 155.5K 142.3K
EPS
Profit Margin 9.6% 10.1% 9.6%
Rev Growth +19.5% +5.1% +5.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.58M 2.06M 2.01M
Total Equity 3.60M 3.62M 3.52M
D/E Ratio 0.44 0.57 0.57
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 279.3K 246.3K 227.4K
Free Cash Flow 124.0K 159.2K 163.1K